Clinical trials
Observational Tuberous Sclerosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 5 |
| Boston Children's Hospital | 2 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| David M. Ritter | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| National Tuberous Sclerosis Association | 1 |
| Sarah Katie Ihnen | 1 |
| St. Jude Children's Research Hospital | 1 |
| Translational Genomics Research Institute | 1 |
| University of Alabama at Birmingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberous Sclerosis | 15 |
| Lymphangioleiomyomatosis | 5 |
| Autistic Disorder | 3 |
| Epilepsy | 2 |
| Lung Diseases | 2 |
| Pneumothorax | 2 |
| Adenomatous Polyposis Coli | 1 |
| Adrenocortical Carcinoma | 1 |
| Anemia, Diamond-Blackfan | 1 |
| Ascites | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.